Articles in section Mergers & Acquisitions
<< Licensing | 613 articles | Opinion & Analysis >> |
Pages 1 2 3 4 5 .. 62 | Next >> |
-
Bristol Myers Squibb Buys Turning Point for US$4.1 B
-
GlaxoSmithKline Acquires Affinivax for US$3.3 B
-
Pfizer Buys Biohaven for US$11.6 B
-
Caladrius and Cend Merge to Become Lisata Therapeutics
-
Regeneron Bolsters I-O Portfolio with US$250 M Checkmate Acquisition
-
GlaxoSmithKline Gets Momelotinib with US$1.9 B Sierra Oncology Buyout
-
Pfizer Bolsters RSV Pipeline with US$525 M ReViral Acquisition
-
Biocon Biologics Acquires Viatris’ Biosimilar Portfolio for US$3.3 B
-
Equillium Acquires Bioniz Therapeutics to Strengthen Immunology Portfolio
-
UCB Acquires Zogenix to Bolster its Epilepsy Portfolio